LC-MS/MS法测定人血浆中丙戊酸的浓度

Determination of valproic acid in human plasma by LC-MS/MS method

目的建立快速、灵敏的液相色谱-串联质谱(LC-MS/MS)法测定人血浆中丙戊酸的浓度。方法采用乙腈沉淀蛋白法处理人血浆样本,选用Shimpack VP-ODS色谱柱(150mm×2.0mm I.D,5μm),以甲醇:5mmol/L乙酸铵(55∶45,v/v)为流动相,流速为0.4mL/min,采用API3200型三重四极杆串联质谱仪的多重反应监测(MRM)扫描方式进行监测,电喷雾离子化源,负离子方式,选择监测离子反应分别为m/z 142.9→m/z 142.9(丙戊酸)和m/z 179.0→m/z 179.0(1-庚烷磺酸)。结果丙戊酸和内标1-庚烷磺酸的保留时间分别为3.03、2.38min;血浆中丙戊酸的线性范围为0.800~80.0μg/mL(r>0.99),定量下限为0.800μg/mL;批内、批间精密度(RSD)均小于15%;准确度(RE)均在±15%的范围以内;平均提取回收率为(84.1±2.4)%;平均基质效应因子为(104.3±2.0)%。稳定性试验中,在各种贮存条件下的血浆中,丙戊酸均较稳定。结论该方法适用于人血浆中丙戊酸浓度的测定及丙戊酸半钠缓释片的人体药代动力学研究。

Objective To develop a rapid and sensitive liquid chromatography-tandem mass spectrometricC LC-MS/MS） method for the determination of valproic acid in human plasma. Methods After treating human plasma sample by acetonitrile protein pre-cipitation method,the analytes were separated on a Shimpack VP-ODS analytical column（150 mm× 2. 0 mm I. D, 5 jum） with the mobile phase of methanol and 5 mmol/L ammonium acetate （55 ： 45,v/v）at a flow rate of 0. 4 mL/min. Detection was carried out by adopting the multiple reaction monitoring（MRM） scanning mode in the API3200 triple quadrupole tandem mass spectrometer, electrospray ionization source,negative ion mode, selected monitoring ionic reactions were m/z 142. 9 -m/z 142. 9 （valproic acid） and m/z 179. 0-m/z 179. 0（l-sulfonic acid）. Results Valproic acid and internal standard 1-sulfonic acid retention time were 3. 03 min and 2. 38 min respectively. The plasma valproic acid linear range was 0. 800 - 80. 0 jng/mL（r〉0. 99） with the lower limit of quantitation（LLOQ） 0. 800 jug/mL. The intra- and inter-batch relative standard deviations（RSD） were both less than 15% ,and the relative errors（RE） were within 土 15 % . The mean extraction recovery rate was（84. 1 ± 2. 4） % , and the mean matrix effect factor was（104. 3 ± 2. 0） %. In the stability study, valproic acid was found to be stable in plasma under various storage conditions. Conclu-sion This method is suitable for the determination of valproic acid in human plasma and human pharmacokinetic study of valproic acid semisodium sustained release tablet.